Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...
Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028 ...
The Portuguese contract development and manufacturing organization (CDMO) Hovione continues its spray drying expansion with ...
The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...
A conversation with Steve Rosenberg, CEO of uMotif electronic clinical outcome assessment (eCOA) - collecting data ...
The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...
We’re thrilled to announce that we have migrated Confectionery News to a new platform. Our expert coverage of the chocolate, ...
CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...
The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...
The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.
By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...
Transforming clinical trials and drug development - panel at DIA Global. 20-Jun-2024 By Liza Laws . During a panel discussion ...